Mark Bunnage

Mark Bunnage is a Visiting Professor in the Department of Chemistry at the University of Oxford. His research interests are not specified in the available information. Dr. Bunnage is affiliated with the Department of Chemistry and can be contacted via email. His profile page indicates his role and affiliation but does not provide further details about his academic background or specific research areas.

Mark Bunnage is a leading expert in medicinal chemistry, chemical biology, and drug discovery. His research focuses on the development of chemical probes and small-molecule inhibitors for therapeutic targets, including bromodomains, methyltransferases, and protein interaction inhibitors. He has contributed to the discovery and optimization of compounds for conditions such as proteinuric kidney disease and chronic obstructive pulmonary disease. His work emphasizes target validation, chemogenomic screening, and the design of selective inhibitors with therapeutic potential. Bunnage's research bridges fundamental chemical biology with translational drug discovery, advancing the understanding of molecular mechanisms in disease.